Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leveraging Technology (STAND-T) to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy

NCT05324098 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT05324098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05324098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leveraging Technology (STAND-T) to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Completed
Start date
March 8, 2022
Completion date
July 31, 2023
Enrollment
47 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer